Scientists at the University of California, Berkeley, have developed an experimental compound that promotes weight loss by increasing energy expenditure rather than suppressing appetite, setting it apart from popular treatments like Wegovy and Ozempic.

During tests involving mice, the substance increased calorie burning by as much as 18 percent while improving blood sugar regulation, decreasing hepatic fat, and reducing body weight without causing substantial muscle wasting. Furthermore, pairing the new compound with current GLP-1 therapeutics yielded enhanced therapeutic outcomes compared to administering either approach independently.

More details are expected as the story develops.